Clinical Trial Update: Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AGN-150998 for exudative age-related macular degeneration completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• AGN-150998

Snippet

Sponsor: Allergan | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2015-06-18